Nutraceuticals
PreclinicalSmall molecule
Nutraceuticals is one of 8 small molecule programs targeting Chronic Fatigue Syndrome. It is currently in Preclinical.
1
Indications
3
Total Trials
0
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Chronic Fatigue Syndrome
#DrugCompanyPhaseTrials
1Xyrem
Jazz PharmaceuticalsApproved
Vyvanse
TakedaApproved
Sunosi
AAxsome Therapeutics, Inc.
Approved
Rituxan
RochePhase 3
Lyrica
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 2
Catapres
Boehringer IngelheimPreclinical
Nutraceuticals
UUniversity of Roma La Sapienza
Preclinical
Poly I-Poly C12U
AAIM ImmunoTech Inc.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Nutraceuticals. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Roma La Sapienza